<table sstyle="width:80%" align="center" border=1>
<tr>
<th>mv</th>
<th>dw</th>
<th>HMMCrowd</th>
</tr>
<tr>
<td width=33%>
[8, 11] safety and efficacy<br>[42, 46] irritability and related behaviors<br>[143, 146] safety; efficacy<br>[180, 181] response<br>[189, 191] adverse events<br>[218, 219] appetite<br>[228, 229] weight<br>[230, 231] vomiting<br>[240, 249] sedation, pyrexia, and upper respiratory tract infection<br>[258, 259] nasopharyngitis<br>[268, 271] somnolence and fatigue<br>[280, 282] Extrapyramidal AEs<br>[294, 296] mean weight<br>[303, 306] body mass index<br>[329, 332] irregular menstruation)<br>[347, 351] sleep visual analog scale<br>[361, 364] efficacy scale scores<br>[373, 375] safety findings<br>[424, 428] irritability and related behaviors<br></td>
<td width=33%>
[8, 11] safety and efficacy<br>[42, 46] irritability and related behaviors<br>[143, 146] safety; efficacy<br>[180, 181] response<br>[189, 191] adverse events<br>[218, 219] appetite<br>[228, 229] weight<br>[230, 231] vomiting<br>[240, 249] sedation, pyrexia, and upper respiratory tract infection<br>[258, 259] nasopharyngitis<br>[268, 271] somnolence and fatigue<br>[280, 282] Extrapyramidal AEs<br>[294, 296] mean weight<br>[303, 306] body mass index<br>[328, 332] (irregular menstruation)<br>[347, 351] sleep visual analog scale<br>[361, 364] efficacy scale scores<br>[373, 375] safety findings<br>[424, 428] irritability and related behaviors<br></td>
<td width=33%>
[8, 11] safety and efficacy<br>[42, 46] irritability and related behaviors<br>[143, 146] safety; efficacy<br>[180, 181] response<br>[189, 193] adverse events (AE<br>[215, 219] AEs were increased appetite<br>[227, 231] increased weight and vomiting<br>[240, 249] sedation, pyrexia, and upper respiratory tract infection<br>[258, 259] nasopharyngitis<br>[268, 271] somnolence and fatigue<br>[280, 282] Extrapyramidal AEs<br>[292, 296] Increase in mean weight<br>[303, 306] body mass index<br>[324, 332] prolactin-related AE (irregular menstruation)<br>[347, 351] sleep visual analog scale<br>[361, 364] efficacy scale scores<br>[373, 375] safety findings<br>[424, 428] irritability and related behaviors<br></td>
</tr>
